Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia

Philadelphia chromosome-positive (Ph+) Acute Lymphoblastic Leukemia (ALL) accounts for 25–30% of adult ALL and its incidence increases with age in adults >40 years old. Irrespective of age, the ABL1 fusion genes are markers of poor prognosis and amplification of the NUP214-ABL1 oncogene can be de...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Simioni, Carolina, Ultimo, Simona, Martelli, Alberto M., Zauli, Giorgio, Milani, Daniela, McCubrey, James A., Capitani, Silvano, Neri, Luca M.
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346755/
https://ncbi.nlm.nih.gov/pubmed/27821800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13035
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires